vision changes on tirzepatide Zepbound and Loss: 20 Frequently Asked Questions Has anyone experienced vision issues

A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv

Patients with a history of pancreatitis should discuss this risk with their provider

The levels of biomarkers such as insulin and glucose are important indicators to evaluate the efficacy of GLP-1 analogues [6]

Preclinical models show faster closure and improved tissue quality compared with conventional materials

A recent study showed that the GLP-1 analog liraglutide exerts a significant improvement of disease activity endpoints, including colonic tissues histological changes and colon weight/length ratio, which might be due to its role in reducing inflammatory cytokines and chemokines, such as chemokine (CC motif) ligand 20 (CCL20), IL-33, and IL-22 (78)